Increasing the Temporal Window in Individuals With Alcohol Use Disorder
RP1A
Reinforcer Pathology 1A: Increasing the Temporal Window
2 other identifiers
interventional
154
1 country
1
Brief Summary
Episodic future thinking (EFT) is based on the new science of prospection, which was first identified in a Science publication in 2007 and refers to pre-experiencing the future by simulation. Considerable evidence suggests that prospection is important for understanding human cognition, affect, motivation, and action. Individuals with damaged frontal areas, as well as individuals with alcohol use disorder (AUD), show deficits in planning prospectively. One systematic method to engender prospection is via EFT. EFT, as applied in our prior studies and in this proposal consists of having participants develop positive plausible future events that correspond to several future time frames (e.g., 2 weeks, 1 month, 3 months etc). For each of these timeframes participants are asked to concretize the events (e.g., What are you doing? Who will be there? What will you see, hear, smell, and feel?). We and others have used EFT to decrease delay discounting (DD) in individuals with AUD and smokers, as well as normal weight, overweight, and obese populations when compared to the control condition, control episodic thinking (CET). Consistent with reinforcer pathology, EFT also reduces alcohol valuation in the purchase task among individuals with AUD. However, no study to date has examined whether EFT reduces alcohol self-administration in the laboratory. Moreover, the neural correlates of EFT in AUD are also unknown. In these studies, we propose to test an intervention, EFT, which we hypothesize will decrease reinforcer pathology measures in a bar-like setting in the laboratory; that is, EFT will decrease delay discounting, as well as alcohol self-administration, demand, and craving compared to a control episodic thinking (CET) condition. Moreover, we hypothesize EFT will enhance activation in brain regions associated with prospection (e.g., hippocampus and amygdala) and the executive decision system (e.g., DLPFC). We will also examine the effect of EFT on real-world drinking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2019
CompletedFirst Posted
Study publicly available on registry
October 14, 2019
CompletedStudy Start
First participant enrolled
November 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedResults Posted
Study results publicly available
January 23, 2026
CompletedJanuary 23, 2026
January 1, 2025
3.8 years
October 9, 2019
September 12, 2025
January 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Delay Discounting (DD) Rates (Studies 1 and 2)
DD rates were measured using an adjusting amount task where participants were presented with hypothetical choices between smaller immediate or larger later amounts of money after a range of delays (1 day-25 years). Individual indifference points were calculated for each delay and then used to estimate DD rates for each participant using Mazur's (1987) equation: V = A/(1+kD), where V is the value of the indifference point, A is the amount of the larger delayed reward, k is the discounting rate, and D is the delay. Discounting rates (k) were then natural-logarithmically transformed (ln(k)). Higher ln(k) indicates steeper discounting and greater reward devaluation with increases in delay, while a lower ln(k) reflects shallower discounting and less reward devaluation with increases in delay. Change in ln(k) will be compared within-subjects between S1 and S2, AND between S1 and S3.
Pre-intervention (S1; baseline measures; Day 1), Post 1st cue generation: S2 (occurs up to 7 days post S1 in Study 1 and 2-3 weeks post S1 in Study 2), and Post 2nd cue generation: S3 (occurs up to 7 days post S2 in Study 1 and 2 weeks post S2 in Study 2)
Intensity of Alcohol Demand (Study 2)
Participants completed a hypothetical Alcohol Purchase Task in which they indicated how many drinks they would purchase at different prices ($0 to $80 per drink). The number of drinks purchased at $0 was used to calculate the intensity of demand. Changes in intensity of alcohol demand were compared within-subjects between S1 and S2, AND between S1 and S3.
Pre-intervention (S1; baseline measure; Day 1), Post 1st cue generation, (S2; approximately 2 weeks post S1), and Post 2nd cue generation (S3; approximately 2 weeks post S2 and 4 weeks post S1)
In-Laboratory Alcohol Consumption (Study 1)
The number of alcoholic beverages purchased/consumed during the self-administration session will be recorded. The average number of drinks consumed will be compared between groups.
Self-Administration session will occur at either Session 2 or Session 3 based on counterbalance assignment. S2 occurs up to 7 days post S1 and S3 occurs up to 7 days post S2.
fMRI Hyper-connectivity Decrease During Delay Discounting (Study 1)
Measured using fMRI during delay discounting task. Whole-brain PPI analysis of right DLPFC between EFT and CET participants. We examined the number of participants whose Right DLPFC was negatively correlated with their Left DLPFC after the intervention. We hypothesize that AUD leads to hyperconnectivity (positive correlations) between these two regions as a compensatory decision-making mechanism, and that EFT should reduce or reverse this connectivity relationship
fMRI session occurred at either Session 2 or Session 3 based on counterbalance assignment. S2 occurred up to 7 days post S1 and S3 occurred up to 7 days post S2.
fMRI Hyper-connectivity Decrease During Alcohol Purchase Task (Study 1)
Measured using fMRI during the alcohol purchase task. Whole-brain PPI analysis of right DLPFC between EFT and CET participants. We examined the number of participants whose Right DLPFC was negatively correlated with their Left DLPFC after the intervention. We hypothesize that AUD leads to hyperconnectivity (positive correlations) between these two regions as a compensatory decision-making mechanism, and that EFT should reduce or reverse this connectivity relationship
fMRI session occurred at either Session 2 or Session 3 based on counterbalance assignment. S2 occurred up to 7 days post S1 and S3 occurred up to 7 days post S2.
Change in Alcoholic Drinks Per Day (Study 2)
Participants self-reported the number of drinks consumed per day via a mobile app during the first five weeks of the study. The first week measured baseline drinking (Pre-intervention), weeks 2-3 measured drinking after the first cue generation (Post 1st cue generation), and weeks 4-5 measured drinking after the second cue generation (Post 2nd cue generation) The number of drinks per day was compared within-subjects and between groups (EFT and CET).
Daily during Pre-intervention (week 1); Post 1st cue generation (weeks 2-3); and Post 2nd cue generation (weeks 4-5).
Study Arms (2)
Episodic Future Thinking (EFT)
EXPERIMENTALParticipants will generate positive future events they are looking forward to at five time points in the future (1 day, 1 week, 1 month, 3 months, 1 year, 5 years, and 25 years). Participants will be reminded of these events using cues throughout the study and instructed to think about these cues as they make their decisions.
Control Episodic Thinking (CET)
SHAM COMPARATORParticipants will generate positive recent past events that have happened to them at five time points in the recent past (last night from 7pm-10pm, yesterday between 4pm-7pm, yesterday between 1pm-4pm, yesterday from 10am-12pm, yesterday between 7am-10am, the night before last between 7pm-10pm, and evening before last between 4pm-7pm). Participants will be reminded of these events using cues throughout the study and instructed to think about these cues as they make their decisions.
Interventions
Participants will generate descriptions of vivid positive future events.
Participants will generate descriptions of vivid positive recent past events.
Eligibility Criteria
You may qualify if:
- High-risk or harmful drinking (measured by AUDIT)
- years of age
- Desire to quit or cut down on their drinking, but do not have proximate plans to enroll in treatment for AUD during the study period
- Report as one of their top three preferred drinks a beverage appropriate for the alcohol self-administration task (Study 1)
You may not qualify if:
- Moderate to severe DSM-5 criteria for substance-use disorders other than alcohol, nicotine, and/or marijuana
- Current diagnosis of any psychotic disorder
- History of seizure disorders or traumatic brain injury
- Contraindication for participation in the self-administration (Study 1) or MRI sessions (Studies 1 and 2)
- Current pregnancy or lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arizona State Universitycollaborator
- Carilion Cliniccollaborator
- University of Kentuckycollaborator
- Virginia Polytechnic Institute and State Universitylead
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator
- McMaster Universitycollaborator
Study Sites (1)
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, 24016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Stephen LaConte
- Organization
- Virginia Tech
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen M LaConte, PhD
Fralin Biomedical Research Institute at VTC
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2019
First Posted
October 14, 2019
Study Start
November 13, 2020
Primary Completion
August 28, 2024
Study Completion
September 30, 2024
Last Updated
January 23, 2026
Results First Posted
January 23, 2026
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be made available upon request after dissemination of results.
- Access Criteria
- Data requests will be reviewed by the principal investigator and data will be shared with the expectation of acknowledgment of funding source and primary study team.
Investigators will adhere to all NIH requirements regarding data sharing. Participant data collected in this project will be de-identified and made available on a shared secured data repository. We will also share the analysis results. As part of this process, all investigators will be required to agree to the following conditions: 1) will adhere to the reporting responsibilities; 2) will not redistribute the data beyond the requesting individual and named collaborators; 3) will give appropriate acknowledgement; 4) will not use the data for commercial purposes; and 5) will obtain appropriate ethical approvals. Results from research conducted will be shared and disseminated, including: regular project meetings, annual meetings, symposia, workshops, and/or conferences for related groups. Manuscripts will be written and submitted for publication in peer-reviewed journals/conferences, following the NIH Public Access Policy guidelines. All necessary ethical approvals will be obtained.